logo

Axonics Modulation Technologies, Inc. (AXNX)



Trade AXNX now with
  Date
  Headline
1/21/2020 6:03:22 AM Axonics Modulation Technologies Reports FDA Approval Of Enhanced Neurostimulator Programmer
1/9/2020 6:03:24 AM Axonics Modulation Technologies Reports Preliminary Revenue Of $10 Mln For Q4
12/19/2019 6:03:17 AM Axonics Says Granted 6 US Patents And Allowed 3 Addl Patents Related To Implantable Sacral Neuromodulation Technology
12/2/2019 6:16:02 AM Axonics Modulation Tech Says Health Canada Approves Full-Body MRI Labeling For Axonics R-SNM System
11/22/2019 4:36:38 PM Axonics Announces Closing Of $110 Mln Public Offering Of Common Stock
11/21/2019 6:03:58 AM Axonics Agrees To Supply The Axonics R-SNM System To University Of Tennessee Medical Center In Knoxville
11/19/2019 9:30:10 PM Axonics Modulation Prices Public Offering Of 5 Mln Shares At $22.00/shr
11/19/2019 4:04:24 PM Axonics Announces Proposed Public Offering Of Common Stock
11/14/2019 6:05:30 AM Axonics(r) Announces FDA Approval For Sacral Neuromodulation System For Urinary Clinical Indications
11/5/2019 6:11:19 AM Axonics Says Prepared To Act Quickly And Defend Itself Aggressively Medtronic Patent Lawsuit
10/7/2019 6:05:16 AM Axonics Achieves Two Milestones That Expand Its Commercial Reach In France And Norway
10/3/2019 6:06:54 AM Axonics Presents Full One-Year Results From ARTISAN-SNM Pivotal Study At AUGS/IUGA Joint Scientific Meeting
10/2/2019 6:05:16 AM Axonics Modulation Tech Agrees To Supply Axonics R-SNM® System To Adult Pediatric Urology And Urogynecology
9/9/2019 6:12:25 AM Axonics Announces FDA Approval For Its Sacral Neuromodulation System
7/29/2019 6:02:47 AM Axonics Announces Publication Of ARTISAN Clinical Study Results In The Journal Of Urology
6/18/2019 6:03:46 AM Axonics Announces FDA Approves Use Of Full-Body MRI For Pivotal Study Patients
4/8/2019 6:04:20 AM Axonics Names Nancy Snyderman And Jane Kiernan To Board
  
 
>